FDA Inspection 1100373 — Amarin Pharma Inc.
The FDA completed an inspection of Amarin Pharma Inc. on Aug 2, 2019 in Bedminster, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 2, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bedminster, NJ (United States)
Additional details
Sponsor, Contract Research Organization